Case Report - (2023) Volume 14, Issue 2
Received: 12-Aug-2019, Manuscript No. JCCR-23-103291;
Editor assigned: 15-Aug-2019, Pre QC No. P-103291 (PQ);
Reviewed: 29-Aug-2019, QC No. Q-103291;
Revised: 14-Jun-2023, Manuscript No. R-103291 (R);
Published:
12-Jul-2023
, DOI: 10.37421/2165-7920.2023.13.1569
Citation: Romera, Angel Garcia. "Severe Complication of a Recently Recognized Condition: Epstein-Barr Virus Positive Mucocutaneous Ulcer." Clin Case Rep 13 (2023): 1569.
Copyright: �© 2023 Romera AG. This is an open-access article distributed under the terms of the creative commons attribution license which permits unrestricted
use, distribution and reproduction in any medium, provided the original author and source are credited.
The incidence of EBV positive mucocutaneous ulcer is likely highly underestimated, given its self-limiting course, in addition to its rarity amongst the spectrum of EBV positive lymphoproliferative disorders with only a limited number of reported cases in the literature. It was first identified in 2010 and is associated with immunosuppression, iatrogenic, primary and age related. A slight female predominance has been reported with a median patient age of 66.4 years. Disruptions in the balance of this interaction are believed to result in the lymph proliferation of various cell derivatives. EBV positive Mucocutaneous Ulcer (EBVMCU) is an indolent condition on this spectrum of LPDs, which localizes to the skin and mucosal surfaces. It is a rare lymph proliferation that gained recognition as a new entity in the 2016 revisions to the World Health Organization classifications.
